AmideBio receives $575,000 in funding

BOULDER – Biotech company AmideBio LLC said Wednesday it has received $575,000 in new equity funding from a group of private investors.

AmideBio will use the money to continue to develop the various biological substances it makes called peptides, the company said in a press statement. The peptides – including ones used in Alzheimer’s research – are made using licensed technology from the University of Colorado.

Misha Plam, company president and chief executive, declined to identity the group of investors.

“Our expertise and novel peptide manufacturing technology provide AmideBio with several advantages over traditional synthetic or recombinant methods,” Plam said. “(They) allow…